Argyrophil cells in the endometrioid carcinoma of the ovary. 1984

G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi

Of 42 endometrioid carcinomas of the ovary examined with Grimelius staining, 19 tumors were found to have argyrophil cells. Argyrophil cells were subgrouped into two types according to the distribution of the argyrophil granules. Type I cells contained argyrophil granules in the basal part of the cytoplasm, and were found in four tumors. Type II cells contained argyrophil granules mainly in the apical portion or throughout the whole cytoplasm, and were found in 14 tumors. Both type I and II cells were found in different areas of one tumor. In type II cells, the distribution of argyrophil granules was similar to that of mucins, and the apical argyrophilia was diminished in varying degrees in some tumors after diastase digestion. The distribution of argyrophil granules paralleled that of secretory granules identified by electron microscopy in the representative tumors of each type. In the immunohistochemical study, somatostatin was found in a tumor with both types of argyrophil cells. Somatostatin-containing cells generally corresponded to type I cells, but were less numerous than argyrophil cells.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D003594 Cytoplasmic Granules Condensed areas of cellular material that may be bounded by a membrane. Cytoplasmic Granule,Granule, Cytoplasmic,Granules, Cytoplasmic
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
July 1967, Southern medical journal,
G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
May 1967, Obstetrics and gynecology,
G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
November 1971, Harefuah,
G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
March 1972, Nihon Sanka Fujinka Gakkai zasshi,
G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
December 1964, American journal of obstetrics and gynecology,
G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
January 1981, Anales de la Real Academia Nacional de Medicina,
G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
April 2023, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
June 1966, Obstetrics and gynecology,
G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
July 2023, Endocrinology, diabetes & metabolism case reports,
G Ueda, and M Yamasaki, and M Inoue, and Y Tanaka, and K Hiramatsu, and Y Inoue, and J Saito, and T Nishino, and K Kurachi
January 1993, European journal of gynaecological oncology,
Copied contents to your clipboard!